ASPIRIN GIVEN TWICE DAILY REDUCED THE PLATELET REACTIVITY MORE THAN ONCE DAILY IN PEOPLE WITH TYPE 2 DIABETES WITHOUT CARDIOVASCULAR DISEASE

Bibliographic Details
Main Authors: YiHong, S, Bethel, M, Holman, R, Sourij, H, Harrison, P, Tucker, L, Kennedy, I, White, S, Hill, L, Oulhaj, A, Coleman, R, Hu, D
Format: Journal article
Published: 2013
_version_ 1826307284569948160
author YiHong, S
Bethel, M
Holman, R
Sourij, H
Harrison, P
Tucker, L
Kennedy, I
White, S
Hill, L
Oulhaj, A
Coleman, R
Hu, D
author_facet YiHong, S
Bethel, M
Holman, R
Sourij, H
Harrison, P
Tucker, L
Kennedy, I
White, S
Hill, L
Oulhaj, A
Coleman, R
Hu, D
author_sort YiHong, S
collection OXFORD
description
first_indexed 2024-03-07T07:00:36Z
format Journal article
id oxford-uuid:ff9f1ad5-94d9-40ee-a2b6-5e590c2d4cee
institution University of Oxford
last_indexed 2024-03-07T07:00:36Z
publishDate 2013
record_format dspace
spelling oxford-uuid:ff9f1ad5-94d9-40ee-a2b6-5e590c2d4cee2022-03-27T13:46:23ZASPIRIN GIVEN TWICE DAILY REDUCED THE PLATELET REACTIVITY MORE THAN ONCE DAILY IN PEOPLE WITH TYPE 2 DIABETES WITHOUT CARDIOVASCULAR DISEASEJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:ff9f1ad5-94d9-40ee-a2b6-5e590c2d4ceeSymplectic Elements at Oxford2013YiHong, SBethel, MHolman, RSourij, HHarrison, PTucker, LKennedy, IWhite, SHill, LOulhaj, AColeman, RHu, D
spellingShingle YiHong, S
Bethel, M
Holman, R
Sourij, H
Harrison, P
Tucker, L
Kennedy, I
White, S
Hill, L
Oulhaj, A
Coleman, R
Hu, D
ASPIRIN GIVEN TWICE DAILY REDUCED THE PLATELET REACTIVITY MORE THAN ONCE DAILY IN PEOPLE WITH TYPE 2 DIABETES WITHOUT CARDIOVASCULAR DISEASE
title ASPIRIN GIVEN TWICE DAILY REDUCED THE PLATELET REACTIVITY MORE THAN ONCE DAILY IN PEOPLE WITH TYPE 2 DIABETES WITHOUT CARDIOVASCULAR DISEASE
title_full ASPIRIN GIVEN TWICE DAILY REDUCED THE PLATELET REACTIVITY MORE THAN ONCE DAILY IN PEOPLE WITH TYPE 2 DIABETES WITHOUT CARDIOVASCULAR DISEASE
title_fullStr ASPIRIN GIVEN TWICE DAILY REDUCED THE PLATELET REACTIVITY MORE THAN ONCE DAILY IN PEOPLE WITH TYPE 2 DIABETES WITHOUT CARDIOVASCULAR DISEASE
title_full_unstemmed ASPIRIN GIVEN TWICE DAILY REDUCED THE PLATELET REACTIVITY MORE THAN ONCE DAILY IN PEOPLE WITH TYPE 2 DIABETES WITHOUT CARDIOVASCULAR DISEASE
title_short ASPIRIN GIVEN TWICE DAILY REDUCED THE PLATELET REACTIVITY MORE THAN ONCE DAILY IN PEOPLE WITH TYPE 2 DIABETES WITHOUT CARDIOVASCULAR DISEASE
title_sort aspirin given twice daily reduced the platelet reactivity more than once daily in people with type 2 diabetes without cardiovascular disease
work_keys_str_mv AT yihongs aspiringiventwicedailyreducedtheplateletreactivitymorethanoncedailyinpeoplewithtype2diabeteswithoutcardiovasculardisease
AT bethelm aspiringiventwicedailyreducedtheplateletreactivitymorethanoncedailyinpeoplewithtype2diabeteswithoutcardiovasculardisease
AT holmanr aspiringiventwicedailyreducedtheplateletreactivitymorethanoncedailyinpeoplewithtype2diabeteswithoutcardiovasculardisease
AT sourijh aspiringiventwicedailyreducedtheplateletreactivitymorethanoncedailyinpeoplewithtype2diabeteswithoutcardiovasculardisease
AT harrisonp aspiringiventwicedailyreducedtheplateletreactivitymorethanoncedailyinpeoplewithtype2diabeteswithoutcardiovasculardisease
AT tuckerl aspiringiventwicedailyreducedtheplateletreactivitymorethanoncedailyinpeoplewithtype2diabeteswithoutcardiovasculardisease
AT kennedyi aspiringiventwicedailyreducedtheplateletreactivitymorethanoncedailyinpeoplewithtype2diabeteswithoutcardiovasculardisease
AT whites aspiringiventwicedailyreducedtheplateletreactivitymorethanoncedailyinpeoplewithtype2diabeteswithoutcardiovasculardisease
AT hilll aspiringiventwicedailyreducedtheplateletreactivitymorethanoncedailyinpeoplewithtype2diabeteswithoutcardiovasculardisease
AT oulhaja aspiringiventwicedailyreducedtheplateletreactivitymorethanoncedailyinpeoplewithtype2diabeteswithoutcardiovasculardisease
AT colemanr aspiringiventwicedailyreducedtheplateletreactivitymorethanoncedailyinpeoplewithtype2diabeteswithoutcardiovasculardisease
AT hud aspiringiventwicedailyreducedtheplateletreactivitymorethanoncedailyinpeoplewithtype2diabeteswithoutcardiovasculardisease